Article Figures & Data
Tables
- Table 1
- Association of Factor I fibrinogen rs6050 C/T polymorphism with recurrent spontaneous miscarriage (RSM) in pregnant Saudi women.
Genotype RSM pregnant Control Patients (RSM pregnant) vs. control n (%) OR n (%) OR OR CI X2 P-value CC 7 (14%) 0.16 13 (26%) 0.35 0.46 0.17 to 1.28 2.23 0.14 CT 31 (62%) 1.63 14 (28%) 0.39 4.18 1.81 to 9.73 11.56 0.001 TT 12 (24%) 0.32 23 (46%) 0.85 0.38 0.16 to 0.87 5.27 0.02 Total 50 50 Alleles frequencies C 45 (45%) 0.82 40 (40%) 0.67 1.22 0.70 to 2.15 T 55 (55%) 1.22 60 (60%) 1.5 0.81 0.46 to 1.43 0.51 0.48 CI: Confidence interval, vs: versus, a p-value of ≤0.05 determined statistical significance, OR: odds ratio, X2: Chi-square
- Table 2
- Recurrent susceptibility to spontaneous miscarriage and Factor I fibrinogen rs6050 C/T polymorphism in non-pregnant Saudi women
Genotype RSM non-pregnant Control Patients (non-pregnant RSM) vs. Control n (%) OR n (%) OR OR CI X2 P-value CC 6 (12%) 0.14 5 (10%) 0.11 1.27 0.35 to 4.32 0.10 0.75 CT 34 (68%) 2.13 14 (28%) 0.39 5.46 2.32 to 12.87 15.87 0.001 TT 10 (20%) 0.25 31 (62%) 1.63 0.15 0.06 to 0.38 18.05 0.001 Total 50 50 Alleles frequencies C 46 (46%) 0.85 24 (24%) 0.32 2.66 1.47 to 4.94 T 54 (54%) 1.17 76 (76%) 3.17 0.37 0.20 to 0.78 10.58 0.001 CI: Confidence interval, vs: versus, A p-value of ≤0.05 determined statistical significance, OR: Odds ratio, X2: Chi-square
- Table 3
- Factor XI plasma thromboplastin rs4253417 C/T polymorphism in pregnant Saudi women experiencing recurrent spontaneous miscarriage.
Genotype RSM pregnant Control Patients (RSM pregnant) vs. Control n (%) OR n (%) OR OR CI X2 P-value CC 15 (30%) 0.43 13 (26%) 0.35 1.23 0.51 to 2.93 0.20 0.66 CT 8 (16%) 0.19 15 (30%) 0.43 0.44 0.17 to 1.17 2.74 0.10 TT 27 (54%) 1.17 22 (44%) 0.79 1.48 0.68 to 3.29 0.99 0.32 Total 50 50 Alleles frequencies C 38 (38%) 0.61 41 (41%) 0.69 0.88 0.50 to 1.56 T 62 (62%) 1.63 59 (59%) 1.44 1.13 0.64 to 2.00 0.19 0.66 CI: Confidence interval, vs: versus, A p-value of ≤0.05 determined statistical significance, OR: Odds ratio, X2: Chi-square
- Table 4
- Factor XI plasma thromboplastin rs4253417 C/T polymorphism in non-pregnant Saudi women with recurrent spontaneous miscarriage.
Genotype RSM non-pregnant Control Patients (RSM non-pregnant) vs. Control n (%) OR n (%) OR OR CI X2 P-value CC 22 (44%) 0.79 22 (44%) 0.79 1.00 0.45 to 2.20 0.00 0.99 CT 6 (12%) 0.14 9 (18%) 0.22 0.64 0.20 to 1.90 0.70 0.40 TT 22 (44%) 0.79 19 (38%) 0.61 1.30 0.58 to 2.85 0.37 0.54 Total 50 50 Alleles frequencies C 50 (50%) 1.00 53 (53%) 1.13 0.88 0.51 to 1.54 T 50 (50%) 1.00 47 (47%) 0.89 1.12 0.65 to 1.96 0.18 0.67 CI: Confidence interval, vs: versus, A p-value of ≤0.05 determined statistical significance, OR: odds ratio, X2: Chi-square
- Table 5
- Comparison of the mean levels of fibrinogen and plasma thromboplastin in Saudi women with recurrent spontaneous miscarriage and healthy controls.
Traits group* Fibrinogen Plasma thromboplastin Non-pregnant Control 3.972 ± 0.104 92.900 ± 4.519† Patient 3.839 ± 0.106 111.360 ± 3.174‡ Significant 0.375 0.001 Pregnant Control 4.813 ± 0.132 94.780 ± 2.385† Patient 4.737 ± 0.135 104.480 ± 3.110‡ Significant 0.687 0.015